ARTICLE | Clinical News
TransMID-107R transferrin mediated delivery of diphtheria toxin regulatory update
December 17, 2001 8:00 AM UTC
The FDA granted orphan drug designation to KSB's TransMid-107R to treat malignant tumors of the central nervous system, especially inoperable high-grade gliomas. KSB said it plans to start Phase III t...